Skip to content

The Impact of Renin-angiotensin System on Brain Activation During Hypoglycaemia in Healthy Men, a PET Study

The Impact of Renin-angiotensin System on Brain Activation During Hypoglycaemia in Healthy Men, a PET Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00264641
Enrollment
20
Registered
2005-12-13
Start date
2006-01-31
Completion date
2008-02-29
Last updated
2017-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment, Hypoglycemia

Keywords

Hypoglycemia, Cognitive impairment, PET, CalCAP

Brief summary

The purpose of this study is to evaluate the cerebral blood flow in subjects with high and low activity in the renin-angiotensin system (RAS).The renin-angiotensin system is a hormone system which is involved in the regulation of the blood pressure. Earlier studies have shown that high RAS activity is associated with a more pronounced cognitive impairment during hypoglycaemia compared to low RAS activity in both type 1 diabetic patients and healthy volunteers. We intend to examine brain activity by oxygen-15 labelled water-PET scanning during hypoglycaemia in response to cognitive function testing in 20 healthy male volunteers with high and low RAS activity, respectively

Detailed description

The purpose of this study is to evaluate the regional cerebral blood flow in subjects with high and low activity in the renin-angiotensin system (RAS). Earlier studies have shown that high RAS activity is associated with a more pronounced cognitive impairment during hypoglycaemia compared to low RAS activity in both type 1 diabetic patients and healthy volunteers. We intend to examine brain activity by oxygen-15 labelled water-PET scanning during hypoglycaemia in response to cognitive function testing in 20 healthy male volunteers with high and low RAS activity, respectively.

Interventions

DRUGHuman insulin

Hyperinsulinaemic induced hypoglycaemia

Sponsors

Rigshospitalet, Denmark
CollaboratorOTHER
Hypoglycaemia Research Group
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

Male Age 18-40 years Right-handed In good general health based on history High/low RAS activity (high ACE activity, A-allele for angiotensin II receptor (subtype 2) and high plasma angiotensinogen, or low ACE activity, low plasma angiotensinogen and not carrier of the A-allele for angiotensin II receptor (subtype 2)). \-

Exclusion criteria

Any evidence of mental, neurological or medical illnesses. The presence of ferromagnetic metal in the body. Claustrophobia Exposure to radiation within the last year \-

Design outcomes

Primary

MeasureTime frameDescription
Cerebral Activation During HypoglycaemiaAfter 4 scans on day 1To compare the high RAS activity vs low RAS activity a Z score was used.

Countries

Denmark

Participant flow

Participants by arm

ArmCount
High RAS Activity
High RAS activity is defined in the protocol
10
Low RAS Activity
Low RAS activity is defined in the protocol
10
Total20

Baseline characteristics

CharacteristicHigh RAS ActivityTotalLow RAS Activity
Age, Continuous26 years
STANDARD_DEVIATION 4.8
26.5 years
STANDARD_DEVIATION 5.2
27 years
STANDARD_DEVIATION 5.6
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
10 Participants20 Participants10 Participants
Region of Enrollment
Denmark
10 participants20 participants10 participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
10 Participants20 Participants10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

Cerebral Activation During Hypoglycaemia

To compare the high RAS activity vs low RAS activity a Z score was used.

Time frame: After 4 scans on day 1

Population: Only data available is between group analysis

ArmMeasureGroupValue (NUMBER)
All Study ParticipantsCerebral Activation During HypoglycaemiaLow RAS>High RAS Right sup frontal gyrus4.85 Z score
All Study ParticipantsCerebral Activation During HypoglycaemiaHigh RAS>Low RAS post entorhinal cortex4.55 Z score

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026